J. Mcgettigan

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

J. Mascola, D. Follmann, S. Spector, 2020, The New England journal of medicine.

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.